moclobemide has been researched along with Cardiac Failure in 2 studies
Moclobemide: A reversible inhibitor of monoamine oxidase type A; (RIMA); (see MONOAMINE OXIDASE INHIBITORS) that has antidepressive properties.
moclobemide : A member of the class of benzamides that is benzamide substituted by a chloro group at position 4 and a 2-(morpholin-4-yl)ethyl group at the nitrogen atom. It acts as a reversible monoamine oxidase inhibitor and is used in the treatment of depression.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Huuskonen, C | 1 |
| Hämäläinen, M | 1 |
| Paavonen, T | 1 |
| Moilanen, E | 1 |
| Mennander, A | 1 |
| Hale, AS | 1 |
1 review available for moclobemide and Cardiac Failure
| Article | Year |
|---|---|
New antidepressants: use in high-risk patients.
Topics: Age Factors; Aged; Antidepressive Agents; Benzamides; Depressive Disorder; Drug Interactions; Epilep | 1993 |
1 other study available for moclobemide and Cardiac Failure
| Article | Year |
|---|---|
Monoamine oxidase A inhibition protects the myocardium after experimental acute volume overload.
Topics: Animals; Atrial Natriuretic Factor; Disease Models, Animal; Heart Failure; Moclobemide; Monoamine Ox | 2019 |